Showing results (631-640 of 1,120) with videos related to
Sort By:
Pageof 112
Epidemiology and Psychiatric Sciences|October 10, 2017
Childhood abuse and psychotic experiences - evidence for mediation by adulthood adverse life eventsV Bhavsar, J Boydell, P McGuire, et al.Standards in Genomic Sciences|November 17, 2015
Complete genome sequence of the thermophilic Acidobacteria, Pyrinomonas methylaliphatogenes type strain K22(T)Kevin C Y Lee, Xochitl C Morgan, Jean F Power, et al.Medical Oncology and Tumor Pharmacotherapy|January 1, 1984
Monoclonal antibodies in the treatment of cancer: preliminary observations and future prospectsR K Oldham, A C Morgan, C S Woodhouse, et al.Journal of Human Hypertension|March 29, 2013
Higher leptin is associated with hypertension: the Multi-Ethnic Study of AtherosclerosisM A Allison, J H Ix, C Morgan, et al.Journal of Orthopaedic Surgery (Hong Kong)|December 29, 2004
Comparing wound complication rates following closure of hip wounds with metallic skin staples or subcuticular vicryl suture: a prospective randomised trialA A Shetty, V S Kumar, C Morgan-Hough, et al.Disability and Rehabilitation|April 1, 1994
Disease, impairment, disability and social handicap: a community based study of people aged 70 years and overA J Campbell, W J Busby, M C Robertson, et al.Biorxiv : the Preprint Server for Biology|July 15, 2025
Micromapping (μMap) of HER2 Across Human Breast Cancers: Photocatalytic Proximity Labeling Identifies Primary Resistance Mechanisms and Functional InteractorsSteve D Knutson, Jacob A Boyer, Danielle C Morgan, et al.Frontiers in Immunology|August 13, 2025
Hyporesponsive fetus-specific T cell responses in multiparous human pregnancyJessica C Morgan, Grace E Hynes, Jared M Pollard, et al.Plos One|May 22, 2013
Prevalence of Batrachochytrium dendrobatidis in Xenopus collected in Africa (1871-2000) and in California (2001-2010)Vance T Vredenburg, Stephen A Felt, Erica C Morgan, et al.Breast Cancer Research and Treatment|December 22, 2014
A preclinical evaluation of the PI3K alpha/delta dominant inhibitor BAY 80-6946 in HER2-positive breast cancer models with acquired resistance to the HER2-targeted therapies trastuzumab and lapatinibN Elster, M Cremona, C Morgan, et al.Pageof 112